Rolf Dominicus

Rolf Dominicus

UNVERIFIED PROFILE

Are you Rolf Dominicus?   Register this Author

Register author
Rolf Dominicus

Rolf Dominicus

Publications by authors named "Rolf Dominicus"

Are you Rolf Dominicus?   Register this Author

4Publications

57Reads

-Profile Views

Methyl aminolevulinate daylight-photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.

Authors:
Sigrid Karrer Roland A G Aschoff Rolf Dominicus Gertraud Krähn-Senftleben Gerd G Gauglitz Abdou Zarzour Nabil Kerrouche Rajeev Chavda Rolf-Markus Szeimies

J Eur Acad Dermatol Venereol 2019 Jan 11. Epub 2019 Jan 11.

Dept. of Dermatology and Allergology, Klinikum Vest GmbH, Recklinghausen, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/jdv.15422DOI Listing
January 2019

Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:
Eggert Stockfleth Ralph von Kiedrowski Rolf Dominicus John Ryan Adam Ellery Meritxell Falqués Nathalie Ivanoff Rosario Rodriguez Azeredo

Dermatol Ther (Heidelb) 2017 Jun;7(2):263

Almirall S.A., Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s13555-017-0179-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453921PMC
June 2017

Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:
Eggert Stockfleth Ralph von Kiedrowski Rolf Dominicus John Ryan Adam Ellery Meritxell Falqués Nathalie Ivanoff Rosario Rodriguez Azeredo

Dermatol Ther (Heidelb) 2017 03 19;7(1):81-96. Epub 2016 Dec 19.

Almirall S.A., Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s13555-016-0161-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336430PMC
March 2017

Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.

Authors:
Rolf Dominicus Florence Galtier Patrick Richard Martine Baudin

Vaccine 2014 Jun 19;32(31):3942-9. Epub 2014 May 19.

Sanofi Pasteur MSD, 162, avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.vaccine.2014.05.034DOI Listing
June 2014